Tony Wood is Senior Vice President of Medicinal Science & Technology, GSK.
He is a member of the R&D Leadership Team, reporting to Hal Barron, President, R&D.
Before joining GSK in October 2017, he was head of Worldwide Research & Development’s Medicinal Sciences at Pfizer. Prior to that he held roles of increasing seniority in chemistry and medicinal sciences across a range of therapy areas. Tony played a leading role in the discovery of Maraviroc, a CCR5 antagonist for the treatment of HIV, and in recognition was awarded the RSC Malcolm Campbell Prize in 2005. He was also co-recipient of the ACS Heroes of Chemistry Prize, the Prix Galien USA and Scrip Awards in 2008, and the PhRMA Discoverers Award in 2010. In 2018 he was elected as a Fellow of the Academy of Medical sciences.
Tony is a named author and inventor on more than 50 publications and patents, and has represented the pharma view on UK funding council review boards, such as EPSRC and BBSRC.
Tony received his BSc and PhD in chemistry from the University of Newcastle upon Tyne, before
completing post-doctoral studies with Professor Steven Ley, FRS at Imperial College in London. He
continues to be a Visiting Professor at the University of Newcastle upon Tyne.